Skip to content

Clinical trials

Completed Diabetes Mellitus, Type 1 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Status: Completed Country / region: Canada Clear all

198 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20032
20042
20059
20066
20076
20088
20092
20105
20113
201214
201311
201415
201514
201615
201713
201810
201912
20209
202110
202215
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed198

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Cliniques de Montreal25
University of Alberta17
Novo Nordisk A/S16
McGill University12
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)12
The Hospital for Sick Children7
Children's Hospital of Eastern Ontario6
Eli Lilly and Company6
McGill University Health Centre/Research Institute of the McGill University Health Centre5
University of Calgary5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 1198
Diabetes Mellitus43
Hypoglycemia39
Diabetes Mellitus, Type 224
Insulin Resistance22
Cardiovascular Diseases4
Diabetic Neuropathies4
Endocrine System Diseases3
Glucose Metabolism Disorders3
Hyperglycemia3

Trials

Showing 1 to 25 of 198. Each trial links to its page on Pharma Observatory.

98 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.